Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ascendis Pharma ADR (NQ: ASND )

107.97 USD -3.17 (-2.85%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 21, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Ascendis Pharma ADR

< Previous 1 2 Next >
Mid-Afternoon Market Update: Pure Storage Rises Following Strong Q2 Results; SelectQuote Shares Plunge
Toward the end of trading Thursday, the Dow traded down 0.38% to 35,270.96 while the NASDAQ fell 0.35% to 14,988.64. The S&P also ... 
Tags Mid/Afternoon Market Update SLQT ASND
From Benzinga
Here's Why Ascendis Pharma Shares Are Surging Higher Today
Approval of the company's weekly growth hormone is making investors smile today. 
Tags PFE OPK ASND
From Motley Fool
What 8 Analyst Ratings Have To Say About Ascendis Pharma
Ascendis Pharma (NASDAQ:ASND) has observed the following analyst ratings within the last quarter: Bullish Somewhat ... 
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
Mid-Day Market Update: Dow Tumbles Over 100 Points; Ascendis Pharma Shares Spike Higher
Midway through trading Thursday, the Dow traded down 0.33% to 35,288.79 while the NASDAQ fell 0.62% to 14,948.24. The S&P also fell, ... 
Tags Intraday Update News Market News
From Benzinga
45 Stocks Moving In Thursday's Mid-Day Session
Gainers Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a ... 
Tags ANF Intraday Update BBW
From Benzinga
See Why Ascendis Pharma Stock Is Shining On Thursday
TheFDA on Wednesday gave a thumbs-uptoAscendis Pharma A/S's(NASDAQ: ASND) long-acting growth hormone ... 
Tags Long Ideas FDA ASND
From Benzinga
Ascendis Stock Surges To 6-Month High; FDA Approval Lands It In A Major Market
Ascendis Pharma won FDA approval to treat children with insufficient growth hormone, and the biotech stock rocketed on Thursday. 
From Investor's Business Daily
Mid-Morning Market Update: Markets Mixed; Dollar General Profit Beats Views
Following the market opening Thursday, the Dow traded up 0.15% to 35,458.00 while the NASDAQ rose 0.02% to 15,044.79. The S&P, ... 
Tags Intraday Update Market News News
From Benzinga
Recap: Ascendis Pharma Q2 Earnings
Shares of Ascendis Pharma (NASDAQ:ASND) rose 23.2% in after-market trading after the company reported Q2 results. Quarterly ... 
Tags Market News Benzinga Earnings
From Benzinga
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CTLT ASND GLUE
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Ascendis Pharma (NASDAQ:ASND) stock increased by 22.69% to $151.73 during Thursday's pre-market session. The ... 
Tags TALS ONVO ASND
From Benzinga
22 Stocks Moving in Thursday's Pre-Market Session
Gainers Good Works Acquisition Corp. (NASDAQ: GWAC) rose 29.8% to $13.01 in pre-market trading. Good Works Acquisition and Cipher ... 
Tags TKAT UUU Top Gainers
From Benzinga
These 2 Stocks Soared Double Digits After Hours
Find out where the big winners were late Wednesday. 
Tags ^IXIC WSM Market News
From Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Ascendis Pharma (NASDAQ:ASND) stock moved upwards by 20.07% to $148.1 during Wednesday's after-market session. This security ... 
Tags CHEK BZI/TFM ASND
From Benzinga
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags LLY VECT AGEN
From Benzinga
Earnings Scheduled For August 25, 2021
Companies Reporting Before The Bell • Jiayin Gr (NASDAQ:JFIN) is projected to report quarterly earnings at $0.21 per ... 
Tags Earnings Scheduled EDAP VIOT
From Benzinga
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings ... 
Tags SESN Benzinga Small Cap
From Benzinga
Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months
All it will take is an FDA approval and a partial repeat of history. 
Tags ASND Market News BMRN
From Motley Fool
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags XCUR CHRS ABCL
From Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags OGN AZN IMGO
From Benzinga
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SCPS OCUL RLMD
From Benzinga
Expert Ratings For Ascendis Pharma
Ascendis Pharma (NASDAQ:ASND) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month ... 
Tags Analyst Ratings Benzinga BZI/AAR
From Benzinga
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags EWTX BPTS NXTC
From Benzinga
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. 
From TalkMarkets
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due ... 
From Benzinga
Ascendis Pharma's TransCon hGH FDA Review Pushed Backed By Three Months
TheFDA has extended the ongoing reviewof the marketing application ofAscendis Pharma A/S's(NASDAQ: ASND) ... 
From Benzinga
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, ... 
From Benzinga
What 5 Analyst Ratings Have To Say About Ascendis Pharma
Ascendis Pharma (NASDAQ:ASND) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 ... 
From Benzinga
Earnings Scheduled For June 1, 2021
Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is expected to report quarterly loss at $0.11 per ... 
From Benzinga
Ascendis Pharma A/S (ASND) Q1 2021 Earnings Call Transcript
ASND earnings call for the period ending March 31, 2021. 
From Motley Fool
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.